Literature DB >> 27812863

The Immortal Senescence.

Anna Bianchi-Smiraglia1, Brittany C Lipchick1, Mikhail A Nikiforov2.   

Abstract

Activation of oncogenic signaling paradoxically results in the permanent withdrawal from cell cycle and induction of senescence (oncogene-induced senescence (OIS)). OIS is a fail-safe mechanism used by the cells to prevent uncontrolled tumor growth, and, as such, it is considered as the first barrier against cancer. In order to progress, tumor cells thus need to first overcome the senescent phenotype. Despite the increasing attention gained by OIS in the past 20 years, this field is still rather young due to continuous emergence of novel pathways and processes involved in OIS. Among the many factors contributing to incomplete understanding of OIS are the lack of unequivocal markers for senescence and the complexity of the phenotypes revealed by senescent cells in vivo and in vitro. OIS has been shown to play major roles at both the cellular and organismal levels in biological processes ranging from embryonic development to barrier to cancer progression. Here we will briefly outline major advances in methodologies that are being utilized for induction, identification, and characterization of molecular processes in cells undergoing oncogene-induced senescence. The full description of such methodologies is provided in the corresponding chapters of the book.

Entities:  

Keywords:  Chromatin modifications; Hayflick limit; Oncogene-induced senescence; RAF; RAS; Senescence; Telomeres; p16INK4a; p21WAF1/CIP1; p53; β-galactosidase

Mesh:

Substances:

Year:  2017        PMID: 27812863      PMCID: PMC5648013          DOI: 10.1007/978-1-4939-6670-7_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  149 in total

Review 1.  Ubiquitination and selective autophagy.

Authors:  S Shaid; C H Brandts; H Serve; I Dikic
Journal:  Cell Death Differ       Date:  2012-06-22       Impact factor: 15.828

Review 2.  Pathways of oncogene-induced senescence in human melanocytic cells.

Authors:  Rajat Bansal; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

3.  A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

Authors:  B D Chang; E V Broude; M Dokmanovic; H Zhu; A Ruth; Y Xuan; E S Kandel; E Lausch; K Christov; I B Roninson
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

Review 4.  Inside and out: the activities of senescence in cancer.

Authors:  Pedro A Pérez-Mancera; Andrew R J Young; Masashi Narita
Journal:  Nat Rev Cancer       Date:  2014-07-17       Impact factor: 60.716

Review 5.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

6.  Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function.

Authors:  Angelika Kren; Vanessa Baeriswyl; François Lehembre; Christoph Wunderlin; Karin Strittmatter; Helena Antoniadis; Reinhard Fässler; Ugo Cavallaro; Gerhard Christofori
Journal:  EMBO J       Date:  2007-05-31       Impact factor: 11.598

Review 7.  Cellular senescence: its role in tumor suppression and aging.

Authors:  Naoko Ohtani; David J Mann; Eiji Hara
Journal:  Cancer Sci       Date:  2009-03-15       Impact factor: 6.716

8.  Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi.

Authors:  Debdutta Bandyopadhyay; Jonathan L Curry; Qiushi Lin; Hunter W Richards; Dahu Chen; Peter J Hornsby; Nikolai A Timchenko; Estela E Medrano
Journal:  Aging Cell       Date:  2007-06-18       Impact factor: 9.304

9.  Comprehensive circular RNA profiling reveals that circular RNA100783 is involved in chronic CD28-associated CD8(+)T cell ageing.

Authors:  Yu-Hong Wang; Xu-Hui Yu; Shan-Shun Luo; Hui Han
Journal:  Immun Ageing       Date:  2015-10-08       Impact factor: 6.400

10.  Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions.

Authors:  Anitha Suram; Jessica Kaplunov; Priyanka L Patel; Haihe Ruan; Aurora Cerutti; Virginia Boccardi; Marzia Fumagalli; Raffaella Di Micco; Neena Mirani; Resham Lal Gurung; Manoor Prakash Hande; Fabrizio d'Adda di Fagagna; Utz Herbig
Journal:  EMBO J       Date:  2012-05-08       Impact factor: 11.598

View more
  2 in total

Review 1.  JMJD3 in the regulation of human diseases.

Authors:  Xiangxian Zhang; Li Liu; Xia Yuan; Yuquan Wei; Xiawei Wei
Journal:  Protein Cell       Date:  2019-11-07       Impact factor: 14.870

Review 2.  mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership.

Authors:  Angel Cayo; Raúl Segovia; Whitney Venturini; Rodrigo Moore-Carrasco; Claudio Valenzuela; Nelson Brown
Journal:  Int J Mol Sci       Date:  2021-07-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.